Star Health and Allied Insurance reported a robust H1 FY27, with net profit rising 57% to Rs 815 crore. Revenue grew 15% to Rs 9,930 crore, supported by a turnaround in underwriting results and a significantly improved combined ratio of 97.9%. The company’s focus on proprietary distribution channels and AI-driven claims processing has effectively bolstered operational efficiency.
Star Health H1 FY27 Profit Jumps 57% to Rs 815 Crore
Profit After Tax rose to Rs 815 crore, while Insurance Revenue climbed to Rs 9,930 crore.
Reader Takeaway: Improved underwriting efficiency and distribution scale drove profitability, though maintaining sub-100% combined ratios remains key.
What just happened
Star Health and Allied Insurance reported strong half-year results for FY27. Profit After Tax (PAT) grew 57% year-on-year to reach Rs 815 crore. Insurance revenue recorded a 15% increase, reaching Rs 9,930 crore compared to Rs 8,641 crore in the same period last year. The company successfully swung from an underwriting loss of Rs 24 crore in H1 FY26 to an underwriting profit of Rs 210 crore in H1 FY27.
Why this matters
The company’s Combined Insurance Service Ratio (CISR) improved to 97.9% from 100.3% in the previous year, indicating a return to underwriting discipline. Additionally, investment income grew 21% to Rs 911 crore, with total investment assets expanding to Rs 22,491 crore. These figures suggest that the company is effectively leveraging its scale to improve margins despite a competitive landscape.
Business and Distribution
Star Health continues to lean heavily on proprietary channels, which now account for over 90% of Gross Written Premium (GWP). Its agency network has expanded to 8.7 lakh agents. Notably, the Digital Direct-to-Consumer (D2C) channel demonstrated rapid growth, with retail fresh GWP rising 137% to Rs 236 crore. The company also reported that 96% of claims are now handled through its new AI-ML powered platform.
Risks to watch
While the financial trajectory is positive, investors should track the company’s debt management, specifically the remaining Rs 70 crore in sub-debt due by November 2026. Long-term performance remains dependent on the firm's "conscious risk-selection" strategy in an increasingly crowded health insurance market.
What to track next
Watch for sustained improvements in the combined ratio and the growth trajectory of the digital D2C segment. Management’s ability to maintain high agent productivity levels will be critical for future top-line growth.